Controversial and divisive: Whitehall's own Big Brother

Some say the Department of Health's commercial directorate employs questionable methods, while others eulogise over its success in getting best value for patients. As a new chief executive takes over, Daloni Carlisle examines the controversies to date

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here